Keith Orford
Director/Board Member bei CALITHERA BIOSCIENCES, INC.
Vermögen: 1 $ am 31.03.2024
Profil
Dr. Keith Orford is a Chief Medical Officer, Executive VP-Clinical at Fog Pharmaceuticals, Inc. He is on the Board of Directors at Calithera Biosciences, Inc. He received his doctorate degree from Georgetown University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.04.2023 | 54 ( 0,00% ) | 1 $ | 31.03.2024 |
Aktive Positionen von Keith Orford
| Unternehmen | Position | Beginn |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 05.11.2021 |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.11.2021 |
Ausbildung von Keith Orford
| Georgetown University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Fog Pharmaceuticals, Inc.
Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Health Technology |
